AL
LXRX icon

Airain Ltd’s Lexicon Pharmaceuticals LXRX Stock Holding History

Airain Ltd’s Portfolio LXRX Stock Details LXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		$779K Buy
+47,363
New +$733K 0.03% 455
2016
Q2 		– Sell
-109,686
Closed -$1.31M – 786
2016
Q1 		$1.31M Buy
109,686
+41,204
+60% +$432K 0.09% 240
2015
Q4 		$911K Buy
+68,482
New +$842K 0.06% 324
2015
Q2 		– Sell
-17,264
Closed -$114K – 990
2015
Q1 		$114K Buy
17,264
+8,026
+87% +$54.8K 0.01% 752
2014
Q4 		$59K Buy
+9,238
New +$74.5K ﹤0.01% 662

Other funds holding LXRX

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UL
Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Airain Ltd's LXRX Position: Q2 2017 in Review

Airain Ltd opened a new position in Lexicon Pharmaceuticals (LXRX) in Q2 2017: 47,363 shares worth $779K. The stake represents 0.03% of the portfolio and ranks #455 among its holdings. This is a return to the name: Airain Ltd previously reported a position in LXRX as recently as Q1 2016.

Airain Ltd first reported a position in LXRX in Q4 2014 and has held it in 5 quarters since. The position peaked at $1.31M in Q1 2016. 135 funds tracked by Wall St. Rank hold LXRX as of Q2 2017.

  • Airain Ltd held 47,363 shares of Lexicon Pharmaceuticals worth $779K as of Q2 2017.
  • Lexicon Pharmaceuticals was a new Airain Ltd position in Q2 2017.
  • Lexicon Pharmaceuticals made up 0.03% of Airain Ltd's portfolio in Q2 2017, its #455 holding.
  • Airain Ltd first reported a position in Lexicon Pharmaceuticals in Q4 2014 and has held it in 5 quarters since.
  • Airain Ltd's Lexicon Pharmaceuticals position peaked at $1.31M in Q1 2016.
  • 135 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.